HIGHLIGHTSFormal centralized and independent analysis of the clinical response data from the ACCENT trial has been undertaken and updated ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

Pancreatic cancer remains one of the deadliest of the major cancers, with a five-year survival rate of only 13%. It’s a ...

Former Sen. Ben Sasse, a Republican from Nebraska, talks with NPR's Steve Inskeep about the state of politics and his life after being diagnosed with terminal pancreatic cancer.

Windows of Opportunity in Breast Cancer: Learning More From Fewer Patients in a Shorter Time This is a US Government work. There are no restrictions on its use. The funder had no role in the design of ...

The FDA gave the go-ahead to Novocure for its tumor-treating electric fields device that targets advanced pancreatic cancer in conjunction with the drugs gemcitabine and nab-paclitaxel. The approval ...

A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows ...

The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy approved in this setting in nearly 30 years. Dubbed Optune Pax, the wearable device ...

Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The ...

With Donald Trump citing education, looks, and thoughts on cutting interest rates, Kevin Warsh emerged as his choice for Fed chairman. Plus, Republicans lose a reliable state Senate seat in Texas, ...

New research uncovered a potential new way to treat pancreatic cancer, the third-deadliest cancer in 2025. The therapy may help human immune cells more effectively attack pancreatic tumors. Below, ...